MENU
SWOBY
AS OF
Jan 13 closing price
Price
$16.90
Change
-$2.65 (-13.55%)
Capitalization
12.53B
21 days until earnings call
Intraday BUY SELL Signals
+Compare
SWOBY
Stock ticker: OTC
AS OF
Jan 13 closing price
Price
$16.90
Change
-$2.65 (-13.55%)
Capitalization
12.53B

SWOBY Swedish Orphan Biovitrum AB Forecast, Technical & Fundamental Analysis

Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology... Show more

SWOBY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SWOBY with price predictions
Jan 13, 2026

SWOBY's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for SWOBY turned positive on January 09, 2026. Looking at past instances where SWOBY's MACD turned positive, the stock continued to rise in of 24 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 27 cases where SWOBY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 74 cases where SWOBY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SWOBY moved out of overbought territory on January 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator moved out of overbought territory. In of the 16 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on January 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SWOBY as a result. In of 34 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

SWOBY moved below its 50-day moving average on January 13, 2026 date and that indicates a change from an upward trend to a downward trend.

SWOBY broke above its upper Bollinger Band on December 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.989) is normal, around the industry mean (29.656). P/E Ratio (24.114) is within average values for comparable stocks, (75.571). Projected Growth (PEG Ratio) (1.810) is also within normal values, averaging (2.019). Dividend Yield (0.034) settles around the average of (0.030) among similar stocks. P/S Ratio (3.888) is also within normal values, averaging (72.365).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SWOBY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SWOBY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
SWOBY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Tomtebodavagen 23 A
Phone
+46 86972000
Employees
1831
Web
https://www.sobi.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GJH9.79N/A
N/A
Synthetic Fixed-Income Sec STRATS 2004-06
IBHE23.16N/A
N/A
iShares iBonds 2025 Term High Yield and Income ETF
EVAV28.62N/A
N/A
Direxion Daily Electric and Autonomous Vehicles Bull 2X Shares
QGRW59.45-0.17
-0.29%
WisdomTree U.S. Quality Growth ETF
KARS32.25-0.22
-0.68%
KraneShares Eltc Vhl and Ft Mbly ETF

Groups containing SWOBY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SWOBY
1D Price
Change %
SWOBY100%
-13.55%
Pharmaceuticals: Generic
industry (218 stocks)
4%
Poorly correlated
+0.27%
Pharmaceuticals
industry (383 stocks)
2%
Poorly correlated
+0.17%